Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 139

    1.

    Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers.

    Rafik Hamad R, Larsson A, Pernow J, Bremme K, Eriksson MJ.

    J Hypertens. 2009 Oct 3. [Epub ahead of print]PMID: 19809366 [PubMed - as supplied by publisher]Related articles

    2.

    Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.

    Jung C, Gonon AT, Sjöquist PO, Lundberg JO, Pernow J.

    Cardiovasc Res. 2009 Sep 18. [Epub ahead of print]PMID: 19726439 [PubMed - as supplied by publisher]Related articles

    4.

    Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo.

    Nathanson D, Erdogdu O, Pernow J, Zhang Q, Nyström T.

    Regul Pept. 2009 Oct 9;157(1-3):8-13. Epub 2009 Jul 10.PMID: 19595708 [PubMed - in process]Related articles

    5.

    Lipid lowering versus pleiotropic effects of statins on skin microvascular function in patients with dysglycaemia and coronary artery disease.

    Settergren M, Böhm F, Rydén L, Pernow J, Kalani M.

    J Intern Med. 2009 Nov;266(5):492-8. Epub 2009 May 7.PMID: 19563393 [PubMed - in process]Related articles

    6.

    Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes.

    Jung C, Rafnsson A, Shemyakin A, Böhm F, Pernow J.

    Int J Cardiol. 2009 Apr 25. [Epub ahead of print]PMID: 19398138 [PubMed - as supplied by publisher]Related articles

    7.

    PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.

    Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjöquist PO, Pernow J.

    Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H719-27. Epub 2009 Jan 16.PMID: 19151258 [PubMed - indexed for MEDLINE]Related articles

    8.

    No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.

    Malmström RE, Settergren M, Böhm F, Pernow J, Hjemdahl P.

    Thromb Haemost. 2009 Jan;101(1):157-64.PMID: 19132203 [PubMed - indexed for MEDLINE]Related articles

    9.

    Endothelial microparticles in patients with insulin resistance.

    Jung C, Shemyakin A, Böhm F, Pernow J.

    Diabetes Metab. 2009 Feb;35(1):71-3. Epub 2009 Jan 4. No abstract available. PMID: 19124261 [PubMed - indexed for MEDLINE]Related articles

    10.

    Association of waist circumference, traditional cardiovascular risk factors, and stromal-derived factor-1 in adolescents.

    Jung C, Fischer N, Fritzenwanger M, Pernow J, Brehm BR, Figulla HR.

    Pediatr Diabetes. 2009 Aug;10(5):329-35. Epub 2008 Dec 5.PMID: 19076302 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease.

    Böhm F, Jensen J, Svane B, Settergren M, Pernow J.

    Can J Physiol Pharmacol. 2008 Nov;86(11):745-51.PMID: 19011669 [PubMed - indexed for MEDLINE]Related articles

    12.

    L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease.

    Settergren M, Böhm F, Malmström RE, Channon KM, Pernow J.

    Atherosclerosis. 2009 May;204(1):73-8. Epub 2008 Sep 4.PMID: 18849028 [PubMed - indexed for MEDLINE]Related articles

    13.

    Improved peripheral perfusion during endothelin--a receptor blockade in patients with type 2 diabetes and critical limb ischemia.

    Kalani M, Pernow J, Bragd J, Jörneskog G.

    Diabetes Care. 2008 Jul;31(7):e56. No abstract available. PMID: 18594055 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.

    Settergren M, Böhm F, Rydén L, Pernow J.

    Eur Heart J. 2008 Jul;29(14):1753-60. Epub 2008 Apr 25.PMID: 18441323 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.

    Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjöquist PO, Pernow J.

    Cardiovasc Res. 2008 Apr 1;78(1):116-22. Epub 2008 Jan 25.PMID: 18222959 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Endothelin-A receptor blockade increases nutritive skin capillary circulation in patients with type 2 diabetes and microangiopathy.

    Settergren M, Pernow J, Brismar K, Jörneskog G, Kalani M.

    J Vasc Res. 2008;45(4):295-302. Epub 2008 Jan 22.PMID: 18212505 [PubMed - indexed for MEDLINE]Related articles

    17.

    The importance of endothelin-1 for vascular dysfunction in cardiovascular disease.

    Böhm F, Pernow J.

    Cardiovasc Res. 2007 Oct 1;76(1):8-18. Epub 2007 Jun 16. Review.PMID: 17617392 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Small skin burn injury reduces cardiac tolerance to ischemia via a tumor necrosis factor alpha-dependent pathway.

    Labruto F, Pernow J, Yang J, Vaage J, Valen G.

    Burns. 2007 Aug;33(5):606-12. Epub 2007 Apr 30.PMID: 17467915 [PubMed - indexed for MEDLINE]Related articles

    19.

    Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease.

    Ahlborg G, Shemyakin A, Böhm F, Gonon A, Pernow J.

    Diabetes Care. 2007 Mar;30(3):591-6.PMID: 17327326 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.

    Bulhak A, Roy J, Hedin U, Sjöquist PO, Pernow J.

    Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3158-63. Epub 2007 Feb 23.PMID: 17322412 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.

    Gonon AT, Bulhak A, Labruto F, Sjöquist PO, Pernow J.

    Basic Res Cardiol. 2007 Jan;102(1):80-9. Epub 2006 Aug 14.PMID: 16900441 [PubMed - indexed for MEDLINE]Related articles

    22.

    Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance.

    Shemyakin A, Böhm F, Wagner H, Efendic S, Båvenholm P, Pernow J.

    J Cardiovasc Pharmacol. 2006 Mar;47(3):385-90.PMID: 16633080 [PubMed - indexed for MEDLINE]Related articles

    23.

    Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo.

    Böhm F, Settergren M, Pernow J.

    Atherosclerosis. 2007 Feb;190(2):408-15. Epub 2006 Mar 9.PMID: 16527283 [PubMed - indexed for MEDLINE]Related articles

    24.

    Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.

    Bulhak AA, Sjöquist PO, Xu CB, Edvinsson L, Pernow J.

    Basic Res Cardiol. 2006 May;101(3):244-52. Epub 2006 Jan 20.PMID: 16411023 [PubMed - indexed for MEDLINE]Related articles

    25.

    Early microvascular dysfunction in healthy normal-weight males with heredity for type 2 diabetes.

    Jörneskog G, Kalani M, Kuhl J, Båvenholm P, Katz A, Allerstrand G, Alvarsson M, Efendic S, Ostenson CG, Pernow J, Wahren J, Brismar K.

    Diabetes Care. 2005 Jun;28(6):1495-7. No abstract available. PMID: 15920077 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition.

    Böhm F, Beltran E, Pernow J.

    J Intern Med. 2005 Mar;257(3):263-71.PMID: 15715683 [PubMed - indexed for MEDLINE]Related articles

    27.

    Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart.

    Gonon AT, Bulhak A, Bröijersén A, Pernow J.

    Br J Pharmacol. 2005 Mar;144(6):860-6.PMID: 15685207 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.

    Bulhak AA, Gourine AV, Gonon AT, Sjöquist PO, Valen G, Pernow J.

    Acta Physiol Scand. 2005 Feb;183(2):151-9.PMID: 15676056 [PubMed - indexed for MEDLINE]Related articles

    29.

    Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischaemia/reperfusion injury via the ET(A) receptor and the mitochondrial K(ATP) channel in the rat in vivo.

    Gourine AV, Molosh AI, Poputnikov D, Bulhak A, Sjöquist PO, Pernow J.

    Br J Pharmacol. 2005 Feb;144(3):331-7.PMID: 15655526 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans.

    Böhm F, Settergren M, Gonon AT, Pernow J.

    Clin Sci (Lond). 2005 Apr;108(4):357-63.PMID: 15610070 [PubMed - indexed for MEDLINE]Related articles

    31.

    Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism.

    Nyström T, Gonon AT, Sjöholm A, Pernow J.

    Regul Pept. 2005 Feb 15;125(1-3):173-7.PMID: 15582729 [PubMed - indexed for MEDLINE]Related articles

    32.

    Evaluation of ST-segment changes during and after maximal exercise tests in one-, two- and three-vessel coronary artery disease.

    Bjurö T, Gullestad L, Endresen K, Nordlander M, Malm A, Höglund L, Wahlqvist I, Pernow J.

    Scand Cardiovasc J. 2004 Oct;38(5):270-7.PMID: 15513309 [PubMed - indexed for MEDLINE]Related articles

    33.

    Endothelin in coronary artery disease.

    Pernow J.

    Scand Cardiovasc J. 2004 Oct;38(5):257-8. No abstract available. PMID: 15513306 [PubMed - indexed for MEDLINE]Related articles

    34.

    Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.

    Gonon AT, Erbas D, Bröijersén A, Valen G, Pernow J.

    Am J Physiol Heart Circ Physiol. 2004 May;286(5):H1767-74. Epub 2003 Dec 23.PMID: 14693683 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    [C-reactive protein potential risk factor for cardiovascular disease]

    Tornvall P, Pernow J, Hansson LO.

    Lakartidningen. 2003 Aug 28;100(35):2691-3. Review. Swedish. PMID: 14531129 [PubMed - indexed for MEDLINE]Related articles

    36.

    L-arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo.

    Pernow J, Bohm F, Beltran E, Gonon A.

    J Appl Physiol. 2003 Dec;95(6):2218-22. Epub 2003 Aug 22.PMID: 12937030 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    The effect of a neuropeptide Y Y1 receptor antagonist in patients with angina pectoris.

    Gullestad L, Bjurø T, Aaberge L, Apelland T, Skårdal R, Kjekshus E, Nordlander M, Ablad B, Pernow J.

    Eur Heart J. 2003 Jun;24(12):1120-7.PMID: 12804926 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.

    Johansson BL, Wahren J, Pernow J.

    Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E864-70. Epub 2003 Jun 10.PMID: 12799312 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Relation of hypertriglyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-reactive protein, interleukin-6, soluble adhesion molecules, von Willebrand factor, and endothelin-1).

    Lundman P, Eriksson MJ, Silveira A, Hansson LO, Pernow J, Ericsson CG, Hamsten A, Tornvall P.

    Am J Cardiol. 2003 May 1;91(9):1128-31. No abstract available. PMID: 12714163 [PubMed - indexed for MEDLINE]Related articles

    40.

    ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men.

    Böhm F, Pernow J, Lindström J, Ahlborg G.

    Clin Sci (Lond). 2003 Feb;104(2):143-51.PMID: 12546636 [PubMed - indexed for MEDLINE]Related articles

    41.

    Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction.

    Ullman B, Pernow J, Lundberg JM, Aström H, Bergfeldt L.

    Clin Sci (Lond). 2002 Dec;103(6):535-42.PMID: 12444905 [PubMed - indexed for MEDLINE]Related articles

    42.

    Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia-reperfusion in vivo.

    Gourine AV, Bulhak AA, Gonon AT, Pernow J, Sjöquist PO.

    Nitric Oxide. 2002 Nov;7(3):210-6.PMID: 12381417 [PubMed - indexed for MEDLINE]Related articles

    43.

    Calcium antagonist clevidipine reduces myocardial reperfusion injury by a mechanism related to bradykinin and nitric oxide.

    Gourine AV, Pernow J, Poputnikov DM, Sjöquist PO.

    J Cardiovasc Pharmacol. 2002 Oct;40(4):564-70.PMID: 12352318 [PubMed - indexed for MEDLINE]Related articles

    44.

    Effects of spontaneous or induced brain ischemia on vessel reactivity: the role of inducible nitric oxide synthase.

    Tokuno S, Chen F, Pernow J, Jiang J, Valen G.

    Life Sci. 2002 Jun 28;71(6):679-92.PMID: 12072156 [PubMed - indexed for MEDLINE]Related articles

    45.

    Pharmacological possibilities for protection against myocardial reperfusion injury.

    Wang QD, Pernow J, Sjöquist PO, Rydén L.

    Cardiovasc Res. 2002 Jul;55(1):25-37. Review.PMID: 12062706 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis.

    Böhm F, Ahlborg G, Johansson BL, Hansson LO, Pernow J.

    Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):674-9.PMID: 11950709 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.

    Böhm F, Ahlborg G, Pernow J.

    Clin Sci (Lond). 2002 Mar;102(3):321-7.PMID: 11869173 [PubMed - indexed for MEDLINE]Related articles

    48.

    Urotensin II evokes potent vasoconstriction in humans in vivo.

    Böhm F, Pernow J.

    Br J Pharmacol. 2002 Jan;135(1):25-7.PMID: 11786476 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1.

    Böhm F, Johansson BL, Hedin U, Alving K, Pernow J.

    Atherosclerosis. 2002 Jan;160(1):215-22.PMID: 11755940 [PubMed - indexed for MEDLINE]Related articles

    50.

    A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation.

    Lundman P, Tornvall P, Nilsson L, Pernow J.

    Atherosclerosis. 2001 Nov;159(1):35-41.PMID: 11689204 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...